Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Expenses (2020 - 2025)

Historic Operating Expenses for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $99.4 million.

  • IDEAYA Biosciences' Operating Expenses rose 4856.86% to $99.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.5 million, marking a year-over-year increase of 955.24%. This contributed to the annual value of $334.0 million for FY2024, which is 11162.57% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Operating Expenses stood at $99.4 million, which was up 4856.86% from $151.1 million recorded in Q4 2024.
  • In the past 5 years, IDEAYA Biosciences' Operating Expenses registered a high of $151.1 million during Q4 2024, and its lowest value of $16.4 million during Q1 2021.
  • For the 5-year period, IDEAYA Biosciences' Operating Expenses averaged around $46.0 million, with its median value being $34.2 million (2023).
  • In the last 5 years, IDEAYA Biosciences' Operating Expenses soared by 2787.65% in 2023 and then soared by 22971.49% in 2024.
  • IDEAYA Biosciences' Operating Expenses (Quarter) stood at $21.3 million in 2021, then surged by 42.82% to $30.5 million in 2022, then skyrocketed by 50.46% to $45.8 million in 2023, then surged by 229.71% to $151.1 million in 2024, then tumbled by 34.24% to $99.4 million in 2025.
  • Its Operating Expenses stands at $99.4 million for Q3 2025, versus $151.1 million for Q4 2024 and $66.9 million for Q3 2024.